STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $256,000 | -55.1% | 52,863 | -1.3% | 0.00% | -100.0% |
Q4 2019 | $570,000 | +9.2% | 53,583 | +7.0% | 0.00% | 0.0% |
Q3 2019 | $522,000 | +60.1% | 50,097 | +135.1% | 0.00% | – |
Q2 2019 | $326,000 | +27.8% | 21,309 | +7.2% | 0.00% | – |
Q1 2019 | $255,000 | +35.6% | 19,882 | +0.5% | 0.00% | – |
Q4 2018 | $188,000 | -83.7% | 19,774 | -22.5% | 0.00% | -100.0% |
Q3 2013 | $1,155,000 | – | 25,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 475,200 | $6,877,000 | 3.03% |
Avoro Capital Advisors LLC | 475,000 | $6,873,000 | 2.64% |
VHCP Management, LLC | 451,400 | $6,532,000 | 1.50% |
Sio Capital Management, LLC | 140,000 | $2,026,000 | 1.15% |
Opus Point Partners Management, LLC | 75,000 | $1,085,000 | 0.91% |
Eventide Asset Management | 620,200 | $8,974,000 | 0.68% |
Telemetry Investments, L.L.C. | 55,000 | $796,000 | 0.44% |
Healthcare Value Capital, LLC | 25,000 | $362,000 | 0.40% |
TFS CAPITAL LLC | 259,916 | $3,761,000 | 0.37% |
FARALLON CAPITAL MANAGEMENT LLC | 672,562 | $9,732,000 | 0.14% |